Display options
Cite
Ochs H, Bodem G, Hahn E, et al. Vergleichende Untersuchungen der biologischen Verfügbarkeit von Digoxin aus Tabletten und Lösung im Langzeitversuch [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)]. Klin Wochenschr. 1975;53(9):425-9doi: 10.1007/BF01493367.
Ochs, H., Bodem, G., Hahn, E., & Dengler, H. J. (1975). Vergleichende Untersuchungen der biologischen Verfügbarkeit von Digoxin aus Tabletten und Lösung im Langzeitversuch [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)]. Klinische Wochenschrift, 53(9), 425-9. https://doi.org/10.1007/BF01493367
Ochs, H, et al. "Vergleichende Untersuchungen der biologischen Verfügbarkeit von Digoxin aus Tabletten und Lösung im Langzeitversuch" [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)]. Klinische Wochenschrift vol. 53,9 (1975): 425-9. doi: https://doi.org/10.1007/BF01493367
Ochs H, Bodem G, Hahn E, Dengler HJ. Vergleichende Untersuchungen der biologischen Verfügbarkeit von Digoxin aus Tabletten und Lösung im Langzeitversuch [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)]. Klin Wochenschr. 1975 May 01;53(9):425-9. doi: 10.1007/BF01493367. German. PMID: 1152354.
Copy Download .nbib Format: NLM
Share it on

Klin Wochenschr. 1975 May 01;53(9):425-9. doi: 10.1007/BF01493367.

[Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].

Klinische Wochenschrift

[Article in German]
H Ochs, G Bodem, E Hahn, H J Dengler

PMID: 1152354 DOI: 10.1007/BF01493367

Abstract

The bioavalability of digoxin tablets and solution has been studied during maintenance therapy in a cross over study. Each preparation was given over a period of at least 7 days to patients with compensated congestive heart failure. Urine concentrations and plasma levels were analysed for digitoxin. There was no significant difference between the two preparations. Determination of steady state serum concentrations and urinary excretion during maintenance therapy as an index of bioavalability are more cumbersome than a single dose study. From a pharmacokinetic point of view however, analyses of steady-state conditions are preferable to a single dose study. In addition, steady state of drug input and output resembles the usual digitalis therapy.

References

  1. Arzneimittelforschung. 1973 Nov;23(11):Suppl:1659-61 - PubMed
  2. Br Med J. 1971 Feb 13;1(5745):380-1 - PubMed
  3. N Engl J Med. 1971 Dec 9;285(24):1344-7 - PubMed
  4. Clin Chim Acta. 1973 Feb 28;44(1):109-17 - PubMed
  5. Lancet. 1972 Aug 12;2(7772):303-7 - PubMed
  6. Circulation. 1966 Nov;34(5):865-74 - PubMed
  7. JAMA. 1972 Nov 20;222(8):957-60 - PubMed
  8. N Engl J Med. 1973 Sep 27;289(13):651-4 - PubMed
  9. N Engl J Med. 1971 Jul 29;285(5):257-9 - PubMed
  10. Lancet. 1971 Oct 23;2(7730):934-5 - PubMed
  11. Lancet. 1972 Jul 8;2(7767):90-1 - PubMed
  12. Klin Wochenschr. 1974 Jul 1;52(13):637-9 - PubMed
  13. Am Heart J. 1962 Apr;63:528-36 - PubMed
  14. Arch Intern Med. 1961 Oct;108:531-9 - PubMed
  15. Med Ann Dist Columbia. 1973 Mar;42(3):137-40 - PubMed
  16. Clin Pharmacol Ther. 1973 Nov-Dec;14(6):949-54 - PubMed
  17. Lancet. 1973 Jun 2;1(7814):1215-7 - PubMed
  18. JAMA. 1973 Apr 9;224(2):199-204 - PubMed
  19. Arzneimittelforschung. 1973 Jan;23(1):64-74 - PubMed
  20. Br Med J. 1973 Mar 24;1(5855):695-7 - PubMed

Substances

MeSH terms

Publication Types